Iran National Blood Transfusion Policy Goals, Objectives and Milestones for 2011-2015

Journal Title: Iranian Journal of Blood and Cancer - Year 2011, Vol 3, Issue 2

Abstract

Transfusion of blood and its components/derivatives is a life saving medical intervention. However, this life saving procedure depends mainly on the availability of sufficient blood and its components in national health sector. Therefore the overall safety of transfusion medicines including the safety of blood and its available components and the appropriate use of these components would directly influence the health care services. To reach to an optimal blood safety, strategies should be defined and implemented in a timely manner. These strategies should include all steps of “vein to vein” chain from blood donor recruitment to appropriate use of blood and blood components. In order to reach such goals Iranian Blood Transfusion Organization has defined essential strategies for developing a suitable blood transfusion system in Iran which are briefly described.

Authors and Affiliations

AM. Cheraghali, S. Amini Kafi-Abad, N Amirizadeh, M. jamali

Keywords

Related Articles

Clinical Significance of Positive Platelet Immunofluorescence Assay in Adult Immune Thrombocytopenia: a Cross Sectional Study

Background: Immune thrombocytopenia is a hematologic disorder characterized by low platelet count and variable bleeding manifestations due to immune-mediated platelet destruction and/or suppression of platelet production...

Prevalence of Osteoporosis among Thalassemia Patients from Zafar Adult Thalassemia Clinic, Iran

Background: The advances in treatment regimes for thalassemic patients have increased the survival among them therefore osteoporosis has emerged as an important cause of morbidity. The aim of this study was to determine...

Antineoplastic Effect of Fenugreek (Trigonella Foenum Graecum) Seed Extract against Acute Myeloblastic Leukemia Cell Line (KG-1)

Background: Treatment of cancer patients using conventional chemotherapy causes serious side effects and, at best, merely extends the patient’s lifespan by a few years. The potential of alternative therapies may therefor...

Obituary: Professor Parvaneh Vossough

This article has no abstract.

Download PDF file
  • EP ID EP371657
  • DOI -
  • Views 64
  • Downloads 0

How To Cite

AM. Cheraghali, S. Amini Kafi-Abad, N Amirizadeh, M. jamali (2011). Iran National Blood Transfusion Policy Goals, Objectives and Milestones for 2011-2015. Iranian Journal of Blood and Cancer, 3(2), 35-42. https://europub.co.uk/articles/-A-371657